AC Immune S.A.
ACIU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50,916 | -$54,233 | -$70,753 | -$72,996 |
| Dep. & Amort. | $2,162 | $2,215 | $2,359 | $2,406 |
| Deferred Tax | $0 | $0 | $0 | $130 |
| Stock-Based Comp. | $5,470 | $4,365 | $3,330 | $4,126 |
| Change in WC | $107,514 | -$15,160 | -$8,432 | $6,841 |
| Other Non-Cash | $1,612 | $2,405 | -$72 | -$6,196 |
| Operating Cash Flow | $65,842 | -$60,408 | -$73,568 | -$65,689 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$576 | -$801 | -$1,239 | -$2,635 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$104,714 | $66,446 | $25,002 | -$51,029 |
| Investing Cash Flow | -$105,290 | $65,645 | $23,763 | -$53,664 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$683 | -$548 | -$569 | $22,950 |
| Stock Issued | $111 | $43,798 | $7 | $17,802 |
| Stock Repurch. | $0 | $0 | -$8 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$548 | $0 | -$776 | -$6 |
| Financing Cash Flow | -$1,120 | $43,250 | -$1,346 | $40,746 |
| Forex Effect | -$1,651 | -$1,579 | $521 | -$70 |
| Net Chg. in Cash | -$42,219 | $46,908 | -$50,630 | -$78,677 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $78,494 | $31,586 | $82,216 | $160,893 |
| End Cash | $36,275 | $78,494 | $31,586 | $82,216 |
| Free Cash Flow | $65,266 | -$61,209 | -$74,807 | -$68,324 |